Skip to main content
. Author manuscript; available in PMC: 2010 Mar 1.
Published in final edited form as: Atherosclerosis. 2008 Jun 13;203(1):67–74. doi: 10.1016/j.atherosclerosis.2008.05.060

Fig. 3.

Fig. 3

Effect of inhibitors to MAPK and NFκb on (a) superoxide anion release and (b) tissue factor activity in pouch macrophages. Inhibitors to p38MAPK, ERK, JNK or NFκb were injected into sterile air pouches of Wistar rats (n = 3 in each group) at least 2 h prior to administration of HCRP (25 μg/mL) or HuSA and superoxide and tissue factor were assessed as described in Section 2. The results are mean ± S.D. #p < 0.05 compared to CRP.